- Home
- CLLS vs SEVN Comparison
CLLS vs SEVN Comparison
Compare CLLS & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- SEVN
- Stock Information
- Founded
- CLLS 1999
- SEVN 1986
- Country
- CLLS France
- SEVN United States
- Employees
- CLLS 216
- SEVN N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- SEVN Real Estate Investment Trusts
- Sector
- CLLS Health Care
- SEVN Real Estate
- Exchange
- CLLS Nasdaq
- SEVN Nasdaq
- Market Cap
- CLLS 148.1M
- SEVN 198.5M
- IPO Year
- CLLS 2007
- SEVN N/A
- Fundamental
- Price
- CLLS $1.48
- SEVN $13.26
- Analyst Decision
- CLLS Buy
- SEVN Strong Buy
- Analyst Count
- CLLS 3
- SEVN 3
- Target Price
- CLLS $7.00
- SEVN $14.50
- AVG Volume (30 Days)
- CLLS 235.1K
- SEVN 51.1K
- Earning Date
- CLLS 11-04-2024
- SEVN 02-18-2025
- Dividend Yield
- CLLS N/A
- SEVN 10.56%
- EPS Growth
- CLLS N/A
- SEVN N/A
- EPS
- CLLS N/A
- SEVN 1.28
- Revenue
- CLLS $36,042,000.00
- SEVN $30,401,000.00
- Revenue This Year
- CLLS $387.77
- SEVN N/A
- Revenue Next Year
- CLLS $11.14
- SEVN N/A
- P/E Ratio
- CLLS N/A
- SEVN $10.36
- Revenue Growth
- CLLS 46.96
- SEVN N/A
- 52 Week Low
- CLLS $1.41
- SEVN $11.23
- 52 Week High
- CLLS $3.38
- SEVN $14.66
- Technical
- Relative Strength Index (RSI)
- CLLS 38.66
- SEVN 57.52
- Support Level
- CLLS $1.65
- SEVN $12.63
- Resistance Level
- CLLS $2.23
- SEVN $12.75
- Average True Range (ATR)
- CLLS 0.18
- SEVN 0.39
- MACD
- CLLS -0.03
- SEVN 0.05
- Stochastic Oscillator
- CLLS 8.54
- SEVN 86.53
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
About SEVN Seven Hills Realty Trust
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in the business of originating and investing in floating rate first mortgage loans secured by the middle market and transitional commercial real estate. Its primary objective is to balance capital preservation with generating risk-adjusted returns.